[Skip to Navigation]
February 1969

Combination Chemotherapy of Chronic

Author Affiliations

From the Medicine Branch, National Cancer Institute (Drs. Foley and Carbone) and Hematology Service, Clinical Pathology Department (Dr. Bennett), Clinical; Center, National Institutes of Health, Bethesda, Md.

Arch Intern Med. 1969;123(2):166-170. doi:10.1001/archinte.1969.00300120054010

Thirteen patients with chronic granulocytic leukemia who had entered an accelerating phase ("blast crisis") of their illness were treated with a combination of agents known to be effective in both acute granulocytic and acute lymphocytic leukemia, (prednisone, mercaptopurine, and methotrexate; vincristine sulfate was added in five instances). Only one complete clinical remission was seen. One marrow remission in the face of increasing adenopathy was seen; there were two partial remissions. The toxicity was severe and included four drug-related deaths.